Next Article in Journal
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen
Next Article in Special Issue
Lactoferrin-Anchored Tannylated Mesoporous Silica Nanomaterials for Enhanced Osteo-Differentiation Ability
Previous Article in Journal
Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration
Previous Article in Special Issue
Engineering Sub-Cellular Targeting Strategies to Enhance Safe Cytosolic Silica Particle Dissolution in Cells
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(11), 1048; https://doi.org/10.3390/pharmaceutics12111048
Action Date Notes Link
article pdf uploaded. 2 November 2020 15:53 CET Version of Record https://www.mdpi.com/1999-4923/12/11/1048/pdf-vor
article supplementary file uploaded. 2 November 2020 15:53 CET - https://www.mdpi.com/1999-4923/12/11/1048#supplementary
article xml file uploaded 4 November 2020 04:35 CET Original file -
article xml uploaded. 4 November 2020 04:35 CET Update https://www.mdpi.com/1999-4923/12/11/1048/xml
article pdf uploaded. 4 November 2020 04:35 CET Updated version of record https://www.mdpi.com/1999-4923/12/11/1048/pdf
article html file updated 4 November 2020 04:37 CET Original file -
article html file updated 22 July 2022 23:35 CEST Update https://www.mdpi.com/1999-4923/12/11/1048/html
Back to TopTop